Literature DB >> 27825544

Multiple biological activities and molecular docking studies of newly synthesized 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcone hybrids.

Rajendran Sribalan1, Govindharasu Banuppriya1, Maruthan Kirubavathi1, A Jayachitra2, Vediappen Padmini3.   

Abstract

A series of fifteen new chemical entities, 3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide chalcones (6a-o), were synthesized as new hybrids with enriched biological activities compared to their parent molecules. The compounds were characterized by 1H NMR, 13C NMR, Mass and IR spectral studies. Their antibacterial, anti-inflammatory and antioxidant activities have been evaluated. These compounds showed moderate to good antibacterial, anti-inflammatory and antioxidant activities. The molecular docking analysis was performed with cyclooxygenase enzyme to ascertain the probable binding model.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Antibacterial; Antioxidant; Chalcone; Pyrazole carboxamide

Mesh:

Substances:

Year:  2016        PMID: 27825544     DOI: 10.1016/j.bmcl.2016.10.075

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Novel 1,3,4-thiadiazole-chalcone hybrids containing catechol moiety: synthesis, antioxidant activity, cytotoxicity and DNA interaction studies.

Authors:  Katarina Jakovljević; Milan D Joksović; Ivana Z Matić; Nina Petrović; Tatjana Stanojković; Dušan Sladić; Miroslava Vujčić; Barbara Janović; Ljubinka Joksović; Snežana Trifunović; Violeta Marković
Journal:  Medchemcomm       Date:  2018-08-23       Impact factor: 3.597

2.  Biological activity evaluation and action mechanism of chalcone derivatives containing thiophene sulfonate.

Authors:  Tao Guo; Rongjiao Xia; Mei Chen; Jun He; Shijun Su; Liwei Liu; Xiangyang Li; Wei Xue
Journal:  RSC Adv       Date:  2019-08-12       Impact factor: 3.361

3.  Rational Design and Synthesis of Diverse Pyrimidine Molecules Bearing Sulfonamide Moiety as Novel ERK Inhibitors.

Authors:  Ahmed H Halawa; Areej A Eskandrani; Walid E Elgammal; Saber M Hassan; Ahmed H Hassan; Hassan Y Ebrahim; Ahmed B M Mehany; Ahmed M El-Agrody; Rawda M Okasha
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.